Apatinib-d8 Hydrochloride - CAS 2468771-44-8
Apatinib-d8 Hydrochloride (CAT: C000565) is a deuterated derivative of Apatinib Hydrochloride, a tyrosine kinase inhibitor used in pharmaceutical research. It functions by selectively targeting and inhibiting the vascular endothelial growth factor receptor-2 (VEGFR-2), a key player in angiogenesis. In the pharmaceutical field, Apatinib-d8 Hydrochloride is a valuable tool compound for studying anti-angiogenic mechanisms and drug interactions. Its stable isotopic labeling with deuterium can aid in drug metabolism and pharmacokinetic studies, making it an asset in drug development research.
* For research use only. Not for human or veterinary use.
|Synonyms||N-[4-(1-Cyanocyclopentyl-d8)phenyl]-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide; YN968D1-d8 Hydrochloride;|
|Molecular Formula:||C₂₄H₁₅D₈N₅O • HCl|
|Solubility||DMSO (Slightly), Methanol (Slightly)|